Vigil

· Gradalis, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Vigil, covering 2017-07-31 to 2025-10-29. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Vigil for Participants With Ovarian Cancer [Phase 2]